Solbar Ningbo Protein Technology Co., Ltd. (SHA:603231)
China · Delayed Price · Currency is CNY 16.66
+0.08 (0.48%)
Sep 14, 2026, 3:00 PM CST
SHA:603231 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,931 | 1,738 | 1,549 | 1,740 | 1,839 | 1,580 |
Other Revenue | 9.92 | 9.92 | 6.08 | 8.49 | 7.93 | 6.41 |
| 1,941 | 1,748 | 1,555 | 1,748 | 1,847 | 1,586 | |
Revenue Growth | 24.63% | 12.39% | -11.04% | -5.33% | 16.44% | 24.05% |
Cost of Revenue | 1,671 | 1,459 | 1,373 | 1,512 | 1,603 | 1,364 |
Gross Profit | 269.64 | 289.51 | 182.7 | 236.62 | 243.89 | 222.02 |
Selling, General & Admin | 66.86 | 68.61 | 61.8 | 55.4 | 47.26 | 46.3 |
Research & Development | 12.17 | 8.12 | 10.41 | 10.45 | 12.24 | 12.39 |
Other Operating Expenses | 1.22 | -1.58 | -4.13 | 5.85 | 6.74 | 4.78 |
Operating Expenses | 80.09 | 74.98 | 67.27 | 73.05 | 67.36 | 68.25 |
Operating Income | 189.55 | 214.53 | 115.42 | 163.56 | 176.52 | 153.77 |
Interest Expense | -0.08 | -0.08 | -0.14 | -2.56 | -5.69 | -2.44 |
Interest & Investment Income | 6.49 | 6.24 | 12.07 | 0.66 | 0.09 | 0.34 |
Currency Exchange Gain (Loss) | 0.32 | 0.32 | 6.54 | 2.1 | 13.19 | -2.88 |
Other Non Operating Income (Expenses) | -13.69 | -1.4 | 3.44 | -0.17 | -0.39 | -0.48 |
EBT Excluding Unusual Items | 182.59 | 219.61 | 137.34 | 163.6 | 183.71 | 148.31 |
Gain (Loss) on Sale of Investments | 5.23 | 5.28 | 6.2 | - | -0.45 | -0.53 |
Gain (Loss) on Sale of Assets | -3.07 | -3.58 | -2.89 | 0.35 | 0.54 | - |
Asset Writedown | -0.24 | -0.23 | - | -4.39 | -3.03 | -9.88 |
Legal Settlements | - | - | - | -2.94 | -0.41 | -0.12 |
Other Unusual Items | 2.51 | 2.51 | 3.41 | 15.63 | 8.21 | 4.75 |
Pretax Income | 187.01 | 223.6 | 144.08 | 172.25 | 188.81 | 142.54 |
Income Tax Expense | 27.61 | 33.88 | 22.9 | 26.26 | 20.79 | 18.6 |
Net Income | 160.42 | 189.72 | 121.18 | 145.98 | 168.03 | 123.94 |
Net Income to Common | 160.42 | 189.72 | 121.18 | 145.98 | 168.03 | 123.94 |
Net Income Growth | 8.53% | 56.56% | -16.99% | -13.12% | 35.57% | 26.80% |
Shares Outstanding (Basic) | 191 | 192 | 192 | 139 | 144 | 144 |
Shares Outstanding (Diluted) | 191 | 192 | 192 | 139 | 144 | 144 |
Shares Change | -0.76% | -0.37% | 38.35% | -3.19% | -0.35% | 0.26% |
EPS (Basic) | 0.84 | 0.99 | 0.63 | 1.05 | 1.17 | 0.86 |
EPS (Diluted) | 0.84 | 0.99 | 0.63 | 1.05 | 1.17 | 0.86 |
EPS Growth | 9.35% | 57.14% | -40.00% | -10.26% | 36.05% | 26.47% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 119.07 | 121.12 | -20.83 | 44.2 | 42.27 | 1.26 |
Free Cash Flow Per Share | 0.62 | 0.63 | -0.11 | 0.32 | 0.29 | 0.01 |
Dividend Per Share | 0.370 | 0.370 | 0.300 | 0.500 | 0.300 | 0.400 |
Dividend Growth | 23.33% | 23.33% | -40.00% | 66.67% | -25.00% | -20.00% |
Gross Margin | 13.89% | 16.56% | 11.75% | 13.53% | 13.21% | 14.00% |
Operating Margin | 9.77% | 12.27% | 7.42% | 9.35% | 9.56% | 9.70% |
Profit Margin | 8.27% | 10.85% | 7.79% | 8.35% | 9.10% | 7.81% |
Free Cash Flow Margin | 6.13% | 6.93% | -1.34% | 2.53% | 2.29% | 0.08% |
EBITDA | 274.23 | 290.75 | 184.01 | 226.37 | 228.47 | 198.35 |
EBITDA Margin | 14.13% | 16.63% | 11.83% | 12.95% | 12.37% | 12.51% |
D&A For EBITDA | 84.68 | 76.22 | 68.59 | 62.81 | 51.94 | 44.58 |
EBIT | 189.55 | 214.53 | 115.42 | 163.56 | 176.52 | 153.77 |
EBIT Margin | 9.77% | 12.27% | 7.42% | 9.35% | 9.56% | 9.70% |
Effective Tax Rate | 14.77% | 15.15% | 15.90% | 15.25% | 11.01% | 13.05% |
Revenue as Reported | 1,748 | 1,748 | 1,555 | 1,748 | 1,847 | - |
Advertising Expenses | - | 0.85 | 0.73 | 0.83 | 0.54 | 0.55 |